Cargando…

Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer

OBJECTIVE: Tumor mutation burden (TMB) represents a useful biomarker for predicting survival outcomes and immunotherapy response. Here, we aimed to conduct TMB-based gene signature and molecular subtypes in gastric cancer. METHODS: Based on differentially expressed genes (DEGs) between high- and low...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Cheng, Li, Minzhe, Lin, Shaofeng, Xiao, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122698/ https://www.ncbi.nlm.nih.gov/pubmed/35601155 http://dx.doi.org/10.1155/2022/4006507

Ejemplares similares

Molecular Subtyping and Prognostic Assessment Based on Tumor Mutation Burden in Patients with Lung Adenocarcinomas
por: Wang, Changzheng, et al.
Publicado: (2019)

Identification of Cuproptosis-Related Subtypes, Establishment of a Prognostic Signature and Characterization of the Tumor Microenvironment in Gastric Cancer
por: Li, Jiazheng, et al.
Publicado: (2023)

Prediction of Two Molecular Subtypes of Gastric Cancer Based on Immune Signature
por: Wu, Dan, et al.
Publicado: (2022)

Signature based on molecular subtypes of deoxyribonucleic acid methylation predicts overall survival in gastric cancer
por: Bian, Jin, et al.
Publicado: (2020)

Significance of a Tumor Mutation Burden Gene Signature with Prognosis and Immune Feature of Gastric Cancer Patients
por: Xiang, Li, et al.
Publicado: (2022)

Characterization of Immune-Related Molecular Subtypes and a Prognostic Signature Correlating With the Response to Immunotherapy in Patients With Gastric Cancer
por: Wang, Gaoming, et al.
Publicado: (2022)

An miRNA signature associated with tumor mutation burden in endometrial cancer
por: Zhou, Hongyu, et al.
Publicado: (2020)

Pyrimidine metabolism regulator-mediated molecular subtypes display tumor microenvironmental hallmarks and assist precision treatment in bladder cancer
por: Wu, Zixuan, et al.
Publicado: (2023)

Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer
por: Kim, Seon-Kyu, et al.
Publicado: (2019)

TNF Family–Based Signature Predicts Prognosis, Tumor Microenvironment, and Molecular Subtypes in Bladder Carcinoma
por: Li, Huihuang, et al.
Publicado: (2022)

Integrated Analysis Identifies Molecular Signatures and Specific Prognostic Factors for Different Gastric Cancer Subtypes()
por: Min, Li, et al.
Publicado: (2016)

Correlate tumor mutation burden with immune signatures in human cancers
por: Wang, Xiaosheng, et al.
Publicado: (2019)

Centrosome Protein 78 Is Overexpressed in Muscle-Invasive Bladder Cancer and Is Associated with Tumor Molecular Subtypes and Mutation Signatures
por: Huang, Xiaoli, et al.
Publicado: (2020)

Immune cell infiltration signatures identified molecular subtypes and underlying mechanisms in gastric cancer
por: Lin, Yilin, et al.
Publicado: (2021)

Molecular Subtypes and CD4(+) Memory T Cell-Based Signature Associated With Clinical Outcomes in Gastric Cancer
por: Ning, Zhi-Kun, et al.
Publicado: (2021)

The Use of Molecular Subtypes for Precision Therapy of Recurrent and Metastatic Gastrointestinal Stromal Tumor
por: Liu, Peng, et al.
Publicado: (2020)

Expression profiles of gastric cancer molecular subtypes in remnant tumors
por: Ramos, Marcus Fernando Kodama Pertille, et al.
Publicado: (2021)

Integration of the Tumor Mutational Burden and Tumor Heterogeneity Identify an Immunological Subtype of Melanoma With Favorable Survival
por: Gao, Yanmei, et al.
Publicado: (2020)

CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancer
por: Cheng, Tianyi, et al.
Publicado: (2022)

Defining muscle-invasive bladder cancer immunotypes by introducing tumor mutation burden, CD8+ T cells, and molecular subtypes
por: Chen, Zihao, et al.
Publicado: (2021)

Molecular Subtyping and Precision Medicine for Pancreatic Cancer
por: Froeling, Fieke E. M., et al.
Publicado: (2021)

Molecular Subtypes and Precision Oncology in Intrahepatic Cholangiocarcinoma
por: Czauderna, Carolin, et al.
Publicado: (2021)

Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy
por: Pham, Timothy V., et al.
Publicado: (2020)

Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma
por: Zhang, Rui, et al.
Publicado: (2021)

Tumor mutational burden and immune signatures interplay in renal cell carcinoma
por: Yakirevich, Evgeny, et al.
Publicado: (2020)

Analysis of Threshold Change of Tumor Mutation Burden in Gastric Cancer
por: He, Xinwei, et al.
Publicado: (2021)

Proteomic Signatures of Diffuse and Intestinal Subtypes of Gastric Cancer
por: Singh, Smrita, et al.
Publicado: (2021)

Proteomic characterization of epithelial ovarian cancer delineates molecular signatures and therapeutic targets in distinct histological subtypes
por: Gong, Ting-Ting, et al.
Publicado: (2023)

Trailblazing Precision Oncology for Rare Tumor Subtypes
por: Shee, Kevin, et al.
Publicado: (2017)

Core immune cell infiltration signatures identify molecular subtypes and promote precise checkpoint immunotherapy in cutaneous melanoma
por: Zhu, Zheng, et al.
Publicado: (2022)

DNA Repair and Replication-Related Gene Signature Based on Tumor Mutation Burden Reveals Prognostic and Immunotherapy Response in Gastric Cancer
por: Zhang, Lei, et al.
Publicado: (2022)

Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy
por: Takamatsu, Shiro, et al.
Publicado: (2022)

Genomic and transcriptomic profiling indicates the prognosis significance of mutational signature for TMB-high subtype in Chinese patients with gastric cancer
por: Cheng, Yanan, et al.
Publicado: (2022)

Molecular subtyping of hepatocellular carcinoma: A step toward precision medicine
por: Wu, Yichao, et al.
Publicado: (2020)

Correlation between LRP1B Mutations and Tumor Mutation Burden in Gastric Cancer
por: Hu, Sizhe, et al.
Publicado: (2021)

miRNA-Based Signature Associated With Tumor Mutational Burden in Colon Adenocarcinoma
por: Xue, Weijie, et al.
Publicado: (2021)

Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4
por: van den Bulk, Jitske, et al.
Publicado: (2019)

Artificial intelligence, molecular subtyping, biomarkers, and precision oncology
por: Shen, John Paul
Publicado: (2021)

Comprehensive analysis of tumor mutation burden and immune microenvironment in gastric cancer
por: Yu, Jie, et al.
Publicado: (2021)

Predicting Peritoneal Dissemination of Gastric Cancer in the Era of Precision Medicine: Molecular Characterization and Biomarkers
por: Chen, Yanyan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dk4p7j9i2qs197qt8mjsbiug45